In patients with non-small-cell lung cancer, FXR was inversely associated with PDL1 expression, and FXR overexpression down-regulated PDL1 via gene trans-repression in cells and synergized with PD1-blocking Ab in syngeneic lung cancer mouse models. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.